NCT02586792View on ClinicalTrials.gov

H7N9 Boost in Healthy Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 12, 2016

Primary Completion Date

December 29, 2016

Study Completion Date

December 29, 2016

Conditions
Influenza
Interventions
BIOLOGICAL

Monovalent influenza A/H7N9 virus vaccine

Monovalent influenza A/H7N9 virus vaccine.

Trial Locations (1)

77030-3411

Baylor College of Medicine - Molecular Virology and Microbiology, Houston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02586792 - H7N9 Boost in Healthy Adults | Biotech Hunter | Biotech Hunter